SCHEMBL4936672

SCHEMBL4936672

CCCCNN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28343355 0.92 ADH1B (0.42)
SCHEMBL10749074 0.92
SCHEMBL11861192 0.89 EPHX1 (0.54)
SCHEMBL6556648 0.89 EPHX1 (0.54)
SCHEMBL9485078 0.89 EPHX1 (0.54)
SCHEMBL3347455 0.89 EPHX1 (0.54)
SCHEMBL17873409 0.89 EPHX1 (0.54)
SCHEMBL14237059 0.89 EPHX1 (0.54)
SCHEMBL2841962 0.89 EPHX1 (0.54)
SCHEMBL9008392 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114561359-A Culture medium for culturing recurrent gastric cancer organoid and application thereof 上海诺典生物科技有限公司 2022-05-31 CN claimed
US-5013751-A (+) Suprofen esters and amides as opthalmic anti-inflammatory agents ALCON LABORATORIES, INC. (US) 1991-05-07 US claimed
US-4988728-A Suprofen derivatives as antiinflammatory agents for eyes ALCON LABORATORIES, INC. (US) 1991-01-29 US claimed
US-11896678-B2 Compositions and methods for treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-02-13 US disclosed
CN-114561359-A Culture medium for culturing recurrent gastric cancer organoid and application thereof 上海诺典生物科技有限公司 2022-05-31 CN disclosed
US-10995091-B2 CXCR4 receptor antagonists PROXIMAGEN LLC (US) 2021-05-04 US disclosed
US-20200179534-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) ACTIVATED CANCER THE BROAD INSTITUTE, INC. (US) 2020-06-11 US disclosed
EP-3600353-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) ACTIVATED CANCER The Broad Institute, Inc. (US) 2020-02-05 EP disclosed
CN-106018624-B The HPLC detection methods of food nitrite nitramine 曲阜师范大学 2018-10-12 CN disclosed
WO-2018183580-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) ACTIVATED CANCER THE BROAD INSTITUTE, INC (US) 2018-10-04 WO disclosed
US-20170226106-A1 CXCR4 Receptor Antagonists PROXIMAGEN, LLC 2017-08-10 US disclosed
US-6838566-B2 Salts of HMG-CoA reductase inhibitors LEK PHARMACEUTICALS D.D. (SI) 2005-01-04 US disclosed
EP-1466886-A2 New salts of HMG-CoA reductase inhibitors Lek Pharmaceutical and Chemical Co. D.D. (SI) 2004-10-13 EP disclosed
EP-1114021-B1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS LEK TOVARNA FARMACEVTSKIH (SI) 2004-07-14 EP disclosed
US-20030120086-A1 New salts of HMG-CoA reductase inhibitors LEK PHARMACEUTICALS D.D. (SI) 2003-06-26 US disclosed
US-6583295-B1 Amine salts of such as lovastatin, pravastatin, simvastatin, mevastatin or atorvastatin LEK PHARMACEUTICALS D.D. (SI) 2003-06-24 US disclosed
EP-1114021-A1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS Lek Pharmaceutical and Chemical Co. D.D. (SI) 2001-07-11 EP disclosed
WO-2000017150-A1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D. (DE) 2000-03-30 WO disclosed
US-4999279-A Polyamide, Unsaturated Monomer, Metal (Meth)acrylate, N-Nitrosoamine Compound; Printed Plates TOYO BOSEKI KABUSHIKI KAISHA (JP) 1991-03-12 US disclosed
EP-0324485-A2 Photosensitive resin composition Toyo Boseki Kabushiki Kaisha (JP) 1989-07-19 EP disclosed